49th ICAAC annual meeting: optimization of anti-infective use in the clinical setting.
The meeting of the American Society of Microbiology was recently held in San Francisco, CA, USA - a gathering of experts in the fields of infectious diseases, microbiology and the pharmaceutical industry, among others. Owing to this large attendance and extensive coverage of many infectious disease topics, we focus on the optimization of anti-infective use in the clinical setting. We will cover antimicrobial stewardship, drugs with Gram-positive activity, and antifungal and antiretroviral agents.
Yeh
Rosa F
RF
Seattle Cancer Care Alliance, Pharmacokinetics Laboratory, 825 Eastlake Ave E, Mail stop G7-405, Seattle, WA 98109, USA. ryeh@seattlecca.org
Jain
Rupali
R
Palmer
Hannah R
HR
D000890:Anti-Infective Agents / Q000009:adverse effects / Q000627:therapeutic use*; D044966:Anti-Retroviral Agents / Q000009:adverse effects / Q000627:therapeutic use; D002140:California; D024881:Drug Resistance, Bacterial; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy / Q000453:epidemiology; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D008829:Microbiology; D009181:Mycoses / Q000188:drug therapy / Q000453:epidemiology; D012958:Societies, Scientific; D014481:United States
D000890:Anti-Infective Agents; D044966:Anti-Retroviral Agents